Posts

, , ,

Princess Marie and her Philanthropic Efforts

Princess MariePrincess Marie of Denmark completes her tenth year working with DanChurchAid, an organization working to combat global poverty. She has also contributed to several other philanthropic organizations over the years. Her Royal Highness actively advocates for the critical cause of diminishing global poverty through her work and commitment.

DanChurchAid

DanChurchAid is an organization that works with economically developing nations to combat hunger, poverty, and oppression. It has been operating for over a hundred years, and with the help of donors, volunteers, and partners, it has aided people in more than 120 countries. The group uses popular and political forces to urge political decision-makers to improve living conditions for the underprivileged. Along with their long-term aid in low- and middle-income countries (LMICs), the organization offers relief to disaster-stricken areas. They make sure that communities reemerge more robustly, and are more adequately prepared if disaster strikes again. The group’s mission emphasizes the importance of human rights as well as working with those in need on relevant, sustainable, and practical projects.

Humanitarian Trips

Through her years as a patron, Princess Marie’s philanthropy has shown through her multiple humanitarian trips with DanChurchAid. During a recent trip to Uganda, she visited the Raising Gabdho Foundation in Kampala. There, she learned more about the foundation’s work, and the techniques they developed to cook in a more sustainable way. She also saw a DanChurchAid project called Fresh Fruit Nexus. The Danish International Development Agency first developed this project in Northern Uganda in 2018. Here, Princess Marie visited Ugandan farmers in the Omugo Refugee Settlement. Together with their refugee families, the farmers formed a cooperative in which they collected crops together and had the opportunity to borrow money from each other.

Princess Marie’s philanthropy extends to other countries as well. She has also traveled to Myanmar in the past. In Myanmar, DanChurchAid has provided underdeveloped communities with practical tools to advance their economic status and quality of life. People have worked to financially organize themselves through savings and loan systems. The underprivileged community could use the money to purchase essential tools, such as sewing machines, for economic sustainability. Princess Marie made this humanitarian trip alongside Danish donors who are also passionate about combating global poverty.

Promoting Sustainability and Accessibility

Another project that Princess Marie was active in is a supermarket called Wefood, which is located in the capital of Copenhagen, Denmark. Her Royal Highness worked with DanChurchAid in unveiling the project. Wefood aims to promote sustainability and accessibility by collecting surplus produce daily and selling it. By using this method, they can cut costs by 30 to 50%. The supermarket has aimed to cut back on food waste and provide food to those affected by poverty. This is the first of its kind in the nation.

In addition to Wefood, Princess Marie has also worked with FoedevareBanken, a Danish food bank. This organization also aims to fight food waste and poverty. Similar to Wefood, they work to provide disadvantaged people with sustainable food, and this initiative ensures that all people can have access to nutritious and balanced meals.

Through her advocacy and patronage with DanChurchAid, Princess Marie has effectively influenced the fight against global poverty. After her ten years with the organization, people worldwide eagerly await to see where Princess Marie’s philanthropy will inspire change next.

– Carly Johnson
Photo: Flickr

, , , , ,

Pharmaceuticals Providing Affordable Medicine in Developing Countries

Affordable Medicine in Developing Countries
In 1997, thousands of people in low-income, developing countries died every day from treatable diseases because they could not pay the high price pharmaceuticals charged for medicine. Today in these same regions, millions are receiving treatment and mortality rates have dropped dramatically as drugmakers around the world are providing affordable medicine in developing countries.

Pharmaceuticals in the Past

In 1997, AIDS was killing thousands of Africans each day. In the same year, people with AIDS in the U.S. were enjoying greater life expectancy and quality of life, with AIDS-related deaths dropping by 42 percent thanks to the use of anti-HIV drugs.  With a $12,000 per patient per year price tag and strict patent laws forbidding the purchase of generic types, these life-saving drugs were inaccessible to millions of AIDS victims in developing countries. Unwilling to lower their prices, the pharmaceutical industry looked on while thousands of people died with treatment just beyond their reach.

Refusing to sit by as its people died every day while a treatment existed, South Africa legalized the suspension of drug patents in 1998, making it possible for South Africans to purchase generic anti-HIV drugs at affordable prices. Thirty-nine top pharmaceutical companies promptly engaged South Africa in a lawsuit, attempting to keep them from accessing HIV drugs at a reduced cost for fear that other countries would follow and the industry would miss out on profits.

The pharmaceuticals soon dropped the lawsuit when the international community received word that drug companies were keeping poor and dying people required medicines. However, drug prices remained inaccessibly high.

Finally, a turning point came in 2001 when Indian drug-maker Cipla shocked the international pharmaceutical industry by announcing its plan to sell anti-HIV drugs directly to poor nations and to Doctors Without Borders for only $350 per patient per year (less than $1 a day). Cipla’s offer exposed the huge markups pharmaceutical companies were profiting from, prompting several major drug-makers to lower their prices and make drugs more accessible to developing countries.

Pharmaceuticals Today

Today, the pharmaceutical industry’s attitude and approach toward providing affordable medicine in developing countries have greatly shifted. The Access to Medicine Foundation shares that nearly all major drug companies have goals for addressing access to medicine now, while many have pioneered innovative ways to reduce costs and create medicines and vaccines for low- and middle-income countries (LMICs). In the past 10 years, drug makers have doubled the number of medicines they are developing for LMICs.

Nine companies that own patents for HIV/AIDS treatment now use their IP rights flexibly to allow LMICs to import and purchase generic supplies. As a result, over 14 million Africans are now on HIV drugs, and AIDS-related deaths dropped drastically by nearly 40 percent over the past 10 years.

Seven drug companies have made efforts to include the poorest populations in their customer base, focusing on products for diabetes, heart disease and other NCDs which are a rising problem in the developing world. In 2017, the leading drug maker, Pfizer, partnered with Cipla to sell chemotherapy drugs to African countries at prices just above their own manufacturing cost, selling some pills for as little as 50 cents.

Several leading pharmaceuticals now partner with generics to produce affordable drugs for Africa, Asia and Latin America, and a fair price strategy now covers 49 percent of products. Thanks to the improvements in the pharmaceutical industry, hundreds of thousands of people now have access to affordable medicine in developing countries.

– Sarah Musick
Photo: Wikimedia Commons